Immunocore Holdings Ltd (IMCR) — Free Cash Flow Generation Index

Latest as of June 2025: 0.98x

Immunocore Holdings Ltd (IMCR) has a Free Cash Flow Generation Index of 0.98x as of June 2025. Free cash flow of $25.55 Million represents 1% of operating cash flow ($25.96 Million). Explore reinvestment intensity of Immunocore Holdings Ltd to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.98x
Free Cash Flow / Operating CF

Free Cash Flow

$25.55 Million
USD

Operating Cash Flow

$25.96 Million
USD

Capital Expenditures

$414.00K
USD

Immunocore Holdings Ltd Free Cash Flow Generation Index (2023–2024)

Historical FCF Generation Index trend for Immunocore Holdings Ltd across 2 annual periods. For the full cash flow conversion analysis, see Immunocore Holdings Ltd (IMCR) cash flow conversion.

Annual Free Cash Flow Generation for Immunocore Holdings Ltd (2023–2024)

Year-by-year Free Cash Flow Generation Index for Immunocore Holdings Ltd. Check Immunocore Holdings Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2024 0.80x $20.89 Million $26.06 Million $5.17 Million ▲ +194.8%
2023 -0.85x $-2.48 Million $2.94 Million $5.42 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).